Suchergebnisse - "Haslwanter, Denise"

PubPharm (18)

1

Structural and mechanistic basis of neutralization by a pan-hantavirus protective antibody

enthalten in: Science translational medicine | 2023

von Mittler, E. | Serris, A. | Esterman, E. | +29

2

Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine : a randomised, placebo-controlled, first-in-human trial

enthalten in: Lancet (London, England) | 2023

von Tschismarov, R. | Van Damme, P. | Germain, C. | +13

CommentIn: Lancet. 2023 Apr 15;401(10384):1242-1243. - PMID 36934735

3

Genomic surveillance of SARS-CoV-2 during the first year of the pandemic in the Bronx enabled clinical and epidemiological inference

enthalten in: Cold Spring Harbor molecular case studies | 2022

von Fels, J. | Khan, S. | Forster, R. | +21

UpdateOf: medRxiv. 2022 Mar 17;:. - PMID 33594384

4

A Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice

enthalten in: PLoS pathogens | 2022

von Malonis, R. | Georgiev, G. | Haslwanter, D. | +9

5

Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naïve and previously infected individuals

enthalten in: EBioMedicine | 2022

von Muena, N. | García-Salum, T. | Pardo-Roa, C. | +18

UpdateOf: medRxiv. 2021 May 18;:. - PMID 34031662

6

Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies

enthalten in: Cell host & microbe | 2022

von Haslwanter, D. | Lasso, G. | Wec, A. | +17

CommentIn: Cell Host Microbe. 2022 Feb 9;30(2):151-153. - PMID 35143767

7

Longitudinally monitored immune biomarkers predict the timing of COVID-19 outcomes

enthalten in: PLoS computational biology | 2022

von Lasso, G. | Khan, S. | Allen, S. | +29

8

Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response

enthalten in: Nature communications | 2021

von Herman, J. | Wang, C. | Loos, C. | +12

UpdateOf: medRxiv. 2021 Mar 11;:. - PMID 33758875

9

A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants

enthalten in: mBio | 2021

von Haslwanter, D. | Dieterle, M. | Wec, A. | +27

10

Single-Dilution COVID-19 Antibody Test with Qualitative and Quantitative Readouts

enthalten in: mSphere | 2021

von Bortz, R. | Florez, C. | Laudermilch, E. | +38

UpdateOf: medRxiv. 2020 Sep 11;:. - PMID 32935116